Pediatric anesthesia & critical care

Prospective Observational Study to Evaluate Post‐Operative Urinary Retention With Pediatric Epidural Analgesia

Paediatr AnaesthPublished Prospective observational study

Authors' conclusion

This study found a rising trend in POUR incidence with age, signifying that older children are more likely to have POUR.

Study context

Population
Children receiving intra- and postoperative epidural analgesia without preoperative catheterization, pediatric surgery, Christian Medical College, Vellore
Participants
157 children
Outcome
Postoperative urinary retention (identified with ultrasound)
Methodological detailssingle-centre, Urinary retention identified with ultrasound and catheterized
  • Single-centre
  • Urinary retention identified with ultrasound and catheterized

Main finding

As reported in the abstract

POUR incidence

Overall incidence of POUR (16 children)

10.2%

Observational data: associations, not effects.

Further findings

OutcomeValuesRR (95% CI)P value
POUR by age<2 years vs ≥2 years · likelihood of voiding≥2 years 12.8% (95% CI 8.0%–19.8%)1.15 (1.07–1.23)
POUR by sexGirls vs BoysGirls 13.2% · Boys 7.9%1.68 (0.66–4.29)P = 0.270
POUR by opioid additiveWithout opioid additive vs With opioid additiveWithout opioid additive 9.6% · With opioid additive 11.1%0.862 (0.338–2.19)
POUR by induction bolus drugBupivacaine vs RopivacaineBupivacaine 10.5% · 13 of 124 · Ropivacaine 9.1% · 3 of 331.15 (0.349–3.81)
OutcomeValues
POUR by surgical duration< 120 min 6.1% · 120 to 180 min 10.8% · > 180 min 16.0%

POUR by age

No POUR in children <2 years (95% CI: 0.0%-10.9%)

Level of epidural placement

Not a significant predictor of POUR

Original publication

Prospective Observational Study to Evaluate Post‐Operative Urinary Retention With Pediatric Epidural Analgesia. Paediatr Anaesth. Published 19 May 2026. doi:10.1002/pan.70223

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.